These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8455961)

  • 1. Methadone in the management of cancer pain: a review.
    Fainsinger R; Schoeller T; Bruera E
    Pain; 1993 Feb; 52(2):137-147. PubMed ID: 8455961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of methadone in the management of pain in cancer patients.
    Bruera E; Neumann CM
    Oncology (Williston Park); 1999 Sep; 13(9):1275-82; discussion 1285-8, 1291. PubMed ID: 10509323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
    Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
    J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the clinical use of methadone for cancer pain.
    Ripamonti C; Zecca E; Bruera E
    Pain; 1997 Apr; 70(2-3):109-15. PubMed ID: 9150283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone use in cancer patients with pain: a review.
    Bruera E; Sweeney C
    J Palliat Med; 2002 Feb; 5(1):127-38. PubMed ID: 11839235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual methadone for the management of cancer-related breakthrough pain: a pilot study.
    Hagen NA; Fisher K; Stiles C
    J Palliat Med; 2007 Apr; 10(2):331-7. PubMed ID: 17472503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home.
    Mercadante S; Casuccio A; Agnello A; Serretta R; Calderone L; Barresi L
    J Clin Oncol; 1998 Nov; 16(11):3656-61. PubMed ID: 9817288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diclofenac does not modify methadone bioavailability in cancer patients.
    Bianchi M; Clavenna A; Groff L; Zecca E; Ripamonti C
    J Pain Symptom Manage; 1999 Apr; 17(4):227-9. PubMed ID: 10203873
    [No Abstract]   [Full Text] [Related]  

  • 11. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of methadone in cancer pain treatment--a review.
    Leppert W
    Int J Clin Pract; 2009 Jul; 63(7):1095-109. PubMed ID: 19570126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized, double-blind study.
    Grochow L; Sheidler V; Grossman S; Green L; Enterline J
    Pain; 1989 Aug; 38(2):151-7. PubMed ID: 2488674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rediscovery of methadone for cancer pain management.
    Clark KJ; Turner K
    Med J Aust; 2001 May; 174(10):547-8. PubMed ID: 11419789
    [No Abstract]   [Full Text] [Related]  

  • 15. Using methadone to treat opioid-induced hyperalgesia and refractory pain.
    Axelrod DJ; Reville B
    J Opioid Manag; 2007; 3(2):113-4. PubMed ID: 17520991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The successful use of parenteral methadone in a patient with a prolonged QTc interval.
    Sekine R; Obbens EA; Coyle N; Inturrisi CE
    J Pain Symptom Manage; 2007 Nov; 34(5):566-9. PubMed ID: 17616330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoclonus associated with high-dose parenteral methadone.
    Ito S; Liao S
    J Palliat Med; 2008 Jul; 11(6):838-41. PubMed ID: 18715174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine.
    Sabatowski R; Kasper SM; Radbruch L
    J Pain Symptom Manage; 2002 Jan; 23(1):3-5. PubMed ID: 11779660
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl.
    Santiago-Palma J; Khojainova N; Kornick C; Fischberg DJ; Primavera LH; Payne R; Manfredi P
    Cancer; 2001 Oct; 92(7):1919-25. PubMed ID: 11745266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone in the management of intractable neuropathic noncancer pain.
    Moulin DE; Palma D; Watling C; Schulz V
    Can J Neurol Sci; 2005 Aug; 32(3):340-3. PubMed ID: 16225176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.